Please complete the CAPTCHA to continue
@paladin-labs.com
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Mark Beaudet is listed as Board Member - Board of Governors at Fondation du Centre universitaire de santé McGill / McGill University Health Centre Foundation, a with 123 employees, based in Greater Montreal Metropolitan Area, Canada. AeroLeads shows a work email signal at paladin-labs.com and a matched LinkedIn profile for Mark Beaudet.
Mark Beaudet previously worked as Board Member at Altus Formulation Inc. and Board Member, Chairman at Ilkos Therapeutic. Mark Beaudet holds B.Comm, Marketing, Entrepreneurship from Mcgill University.
This section adds company-level context without repeating Mark Beaudet's masked contact details.
AeroLeads found 2 current-domain work email signals for Mark Beaudet. Compare company email patterns before reaching out.
Mark Beaudet is a co-founder of Paladin Labs Inc., a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products, that was acquired by Endo International plc in 2014 for approximately $3.0 billion. Since Paladin’s founding in 1996, Mr. Beaudet served as a member of the board of directors and as the company’s Vice President of Sales and Marketing until 2011 when he became interim President and CEO. Following Endo’s acquisition of Paladin, Mr. Beaudet joined the Endo International plc. executive leadership team and continued to lead the Paladin team until his departure in June 2016. Prior to his work with Paladin, Mr. Beaudet held marketing management positions at Procter & Gamble Canada and Pizza Hut Canada. Mr. Beaudet is a member of the board of directors of the McGill University Health Center Foundation, Loyola High School and the Loyola High School Foundation. Mr. Beaudet also serves on the board of Altus Formulations Inc., a privately held drug formulation and development company. He is a former member of the board and former Chair of the Regulatory Affairs Committee of Innovative Medicines Canada (formerly Rx&D - Canada’s Research Based Pharmaceutical Industry Association). Mr. Beaudet holds a B.Comm in Marketing and Entrepreneurship from McGill University and is recognized as a Certified Market Research Professional (CMRP) by the Canadian Market Research and Intelligence Association and as an Accredited Pharmaceutical Manufacturer’s Representative by the Council for Continuing Pharmaceutical Education (CCPE). In 2003 Mr. Beaudet was a co-recipient of the Ernst and Young Entrepreneur of the Year award in the Quebec Life Sciences Sector. In 2015 Mr. Beaudet was inducted into the Canadian Healthcare Marketing Hall of Fame.
Listed skills include Pharmaceutical Industry, Product Launch, Pharmaceutical Sales, Strategic Planning, and 30 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
The Board of Governors for McGill University Health Care Foundation maintains and develops relationships with former Board members and others to boost fundraising and cultivate strong advocates for the Foundation.
Altus Formulation is a drug formulation and development company leveraging our patented drug delivery technologies to provide innovative, cost-effective and safer to use formulations for our clients and their patients.
Laval, Quebec
ILKOS THERAPEUTICS Inc., a new Québec biotechnology firm tasked with the development of S42909, a compound indicated in the oral treatment of venous lower limb ulcers, a disease that affects 1% to 1.5% of the population, mainly older people. Current treatment, which besides being only moderately effective for complete wound healing and limited to compression bandages and local wound care, is labour intensive, accounting for 1.5% to 2% of the health care budget in countries such as Canada. The new treatment, which seeks to become the first line treatment for venous lower limb ulcers, is a potentially major clinical breakthrough.The compound has shown promising pharmacological wound healing properties in preclinical trials and was proven to be safe in phase 1 clinical trials on more than 300 healthy volunteers.The project headed by ILKOS THERAPEUTICS involves demonstrating the efficacy of the compound during a phase 2A multicentre trial conducted in North America and Europe and involving more than 200 patients.
Cipher develops and acquires best-in-class skin care solutions for unmet medical needs. Our innovative dermatology products provide efficacy, flexibility and convenience across a broad range of skin conditions. We are committed to offering healthcare professionals better products that will address their patients’ needs and enrich their practices.
Other employees you can reach at muhcfoundation.com. View company contacts for 123 employees →
Line Larocque
Colleague at Fondation Du Centre Universitaire De Santé Mcgill / Mcgill University Health Centre FoundationTerrebonne, Quebec, Canada
View →
JP
Janick Perrier
Colleague at Fondation Du Centre Universitaire De Santé Mcgill / Mcgill University Health Centre FoundationMontreal, Quebec, Canada
View →
KN
Keisuke Nakazawa
Colleague at Fondation Du Centre Universitaire De Santé Mcgill / Mcgill University Health Centre FoundationJapan
View →
MA
Marie Antonacci
Colleague at Fondation Du Centre Universitaire De Santé Mcgill / Mcgill University Health Centre FoundationMontreal, Quebec, Canada
View →
PE
Patricia Eigan
Colleague at Fondation Du Centre Universitaire De Santé Mcgill / Mcgill University Health Centre FoundationSaint-Clet, Quebec, Canada
View →
AC
Angela Colucci
Colleague at Fondation Du Centre Universitaire De Santé Mcgill / Mcgill University Health Centre FoundationMontreal, Quebec, Canada
View →
LC
Lily Chu
Colleague at Fondation Du Centre Universitaire De Santé Mcgill / Mcgill University Health Centre FoundationMontreal, Quebec, Canada
View →
KR
Katja Reyes-Brown
Colleague at Fondation Du Centre Universitaire De Santé Mcgill / Mcgill University Health Centre FoundationGreater Paris Metropolitan Region, France
View →
JP
Janick Perrier
Colleague at Fondation Du Centre Universitaire De Santé Mcgill / Mcgill University Health Centre FoundationMontreal, Quebec, Canada
View →
PL
Patricia Lefebvre
Colleague at Fondation Du Centre Universitaire De Santé Mcgill / Mcgill University Health Centre FoundationMontreal, Quebec, Canada
View →
Quick answers generated from the profile data available on this page.
Mark Beaudet works for Fondation du Centre universitaire de santé McGill / McGill University Health Centre Foundation.
Mark Beaudet is listed as Board Member - Board of Governors at Fondation du Centre universitaire de santé McGill / McGill University Health Centre Foundation.
AeroLeads has found 2 work email signals at @paladin-labs.com for Mark Beaudet at Fondation du Centre universitaire de santé McGill / McGill University Health Centre Foundation.
Mark Beaudet is based in Greater Montreal Metropolitan Area, Canada while working with Fondation du Centre universitaire de santé McGill / McGill University Health Centre Foundation.
Mark Beaudet has worked for Fondation Du Centre Universitaire De Santé Mcgill / Mcgill University Health Centre Foundation, Altus Formulation Inc., Ilkos Therapeutic, Cipher Pharmaceuticals Inc., and Paladin Labs.
Mark Beaudet's colleagues at Fondation du Centre universitaire de santé McGill / McGill University Health Centre Foundation include Line Larocque, Janick Perrier, Keisuke Nakazawa, Marie Antonacci, and Patricia Eigan.
You can use AeroLeads to view verified contact signals for Mark Beaudet at Fondation du Centre universitaire de santé McGill / McGill University Health Centre Foundation, including work email, phone, and LinkedIn data when available.
Mark Beaudet holds B.Comm, Marketing, Entrepreneurship from Mcgill University.
Mark Beaudet is listed with skills including Pharmaceutical Industry, Product Launch, Pharmaceutical Sales, Strategic Planning, Marketing Strategy, Market Research, Marketing, and Marketing Management.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contactsCheck these profiles if this is not the Mark Beaudet you were looking for.
